EssilorLuxottica Unsponsored ADR (OTCMKTS:ESLOY – Get Free Report) was the recipient of a significant decline in short interest in June. As of June 30th, there was short interest totaling 39,841 shares, a decline of 79.3% from the June 15th total of 192,041 shares. Currently, 0.0% of the shares of the stock are sold short. Based on an average daily trading volume, of 280,156 shares, the short-interest ratio is currently 0.1 days.
EssilorLuxottica Stock Performance
Shares of EssilorLuxottica stock traded down $0.27 on Friday, hitting $97.79. The company’s stock had a trading volume of 61,664 shares, compared to its average volume of 111,231. EssilorLuxottica has a 52-week low of $91.57 and a 52-week high of $186.81. The firm has a fifty day moving average price of $100.52 and a 200-day moving average price of $123.90. The company has a debt-to-equity ratio of 0.17, a current ratio of 0.99 and a quick ratio of 0.70.
Wall Street Analyst Weigh In
A number of research analysts have issued reports on the stock. Zacks Research cut shares of EssilorLuxottica from a “hold” rating to a “strong sell” rating in a report on Tuesday, June 23rd. Deutsche Bank Aktiengesellschaft started coverage on EssilorLuxottica in a report on Tuesday, May 12th. They issued a “hold” rating on the stock. Two equities research analysts have rated the stock with a Strong Buy rating, five have assigned a Buy rating, one has assigned a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, EssilorLuxottica currently has a consensus rating of “Moderate Buy”.
About EssilorLuxottica
EssilorLuxottica SE is a global ophthalmic optics company formed through the 2018 merger of France-based Essilor and Italy-based Luxottica. Headquartered near Paris, the company combines lens manufacturing, frame design and production, brand management and retail operations to provide a vertically integrated offering across the vision care value chain. Its activities span product research and development, manufacturing, wholesale distribution and retailing of spectacles, sunglasses and ophthalmic lenses.
The company’s product portfolio includes prescription and non-prescription lenses, lens coatings and treatments, and an array of eyewear brands and frames.
Featured Articles
- Five stocks we like better than EssilorLuxottica
- 3 Rare-Earth ETFs That Help Investors Balance Exposure and Risk
- Microsoft Bets on In-House AI to Cut OpenAI and Anthropic Costs
- Delta Air Lines Lives Up to Its Claims: Shares Can Keep Climbing
- This Dividend ETF Choice Could Shape Your Income Strategy Through 2026
Receive News & Ratings for EssilorLuxottica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for EssilorLuxottica and related companies with MarketBeat.com's FREE daily email newsletter.
